Evidence map›Paper›PMID 42293592›Full record

ReviewFrontiers in public health2026

Problematic use of generative artificial intelligence chatbots: current stage of conceptual and clinical understanding.

Octavian Vasiliu

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Octavian VasiliuDiscipline of Psychiatry II, Department of Clinical Neurosciences, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential negative consequences of generative AI are the subject of intense debate, with pragmatic and theoretical arguments and counterarguments advanced by mental health specialists, researchers, and policymakers regarding its impact on creativity, overall functioning, and psychosocial wellbeing. The current narrative review addresses historical and conceptual developments in the problematic use of generative AI chatbots (PUGAIC) and empirical findings on its epidemiology, risk factors, assessment instruments, and proposed pathophysiological mechanisms, without advancing PUGAIC as a formally established diagnostic entity. Preliminary data suggest that emotional attachment, anthropomorphism, instant reinforcement, and parasocial dynamics may contribute to compulsive use of generative AI in vulnerable individuals. However, current evidence remains limited, without clinical correlates, predominantly cross-sectional, and culturally constrained. Existing measurement tools are in early stages of validation, and diagnostic boundaries between high engagement in generative AI-related activities, problematic use, and addiction-like behavior remain unclear. While moral apprehension and overpathologization are pitfalls that should be avoided, clinicians have to remain attentive to cases involving functional impairment, psychological distress, and loss of control. In conclusion, based on the available data, PUGAIC may be conceptualized as a potential spectrum phenomenon embedded within broader psychosocial vulnerabilities rather than as an established clinical disorder. Longitudinal research, cross-cultural validation of instruments, and neurocognitive investigations are needed to clarify its nosological status and inform preventive and therapeutic strategies.

Indexed as

Generative Artificial IntelligenceInternet Addiction DisorderHumansRisk Factorsbehavioral addictionchatbotsgambling disordergaming disordergenerative AIpostmodernismproblematic use of the internet

Identifiers

PMID42293592
PMCPMC13253970

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.